Copyright
©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 234-254
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.234
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.234
Figure 2 Tongxinluo promoted arteriogenesis in the ischemic hindlimb.
A: Representative whole-mount images of Microfil vascular casting of mouse limbs; B and C: Collateral vessels are indicated by white arrows and were quantified by micro- computed tomography analysis to determine the vessel volume and surface area; D: Immunofluorescence staining for CD31 (red) and α-SMA (green) to evaluate the capillary density and arterioles in the ischemic adductor (200×, bar=100 μm); E-F: Quantification of the mean fluorescence density of CD31 and α-SMA. All the values are shown as the means ± SDs. aP < 0.05 compared with the normal group, bP <0.05 compared with the model group, cP < 0.05 compared with the Tongxinluo group, n = 3-6. TXL: Tongxinluo.
- Citation: Gu JJ, Hou YL, Yan YH, Li J, Wei YR, Ma K, Wang XQ, Zhang JH, Wang DD, Li CR, Li DQ, Sun LL, Gao HL. Tongxinluo promotes endothelium-dependent arteriogenesis to attenuate diabetic peripheral arterial disease. World J Diabetes 2023; 14(3): 234-254
- URL: https://www.wjgnet.com/1948-9358/full/v14/i3/234.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i3.234